SPR-grade sensitivity. Microarray scale.

IRIS measures label-free binding kinetics across dozens of ligands at once, with no reference channel, no bulk-effect correction, and curves that fit the model.

Live sensor output during a run. Each probe spot brightens as bound material accumulates on it, and every spot’s signal, traced over time, is a binding curve. Ringed spots are labelled by analyte, with R for reference.

Backed by 18 years
of published results.

IRIS instruments run in more than ten research institutions, and independent groups publish with them. The technology is also the subject of 25 PhD dissertations.

18

years continuously in print, 2008 to 2025

the publication record
3,472

citations across 75 publications

Google Scholar, checkable to the row
36

journals, from PNAS to Nature Communications

start with eight

Why it belongs in your lab.

Multiplexed by design

IRIS chips are spotted with different capture agents in a microarray format, so multiple analytes are measured in a single experiment. The same feature makes the platform efficient for antibody and antibody-pair selection during immunoassay development. Discovery programs that train models on binding data need that data in volume: one IRIS run returns a full kinetic trace for every spot on the chip.

Sub-pg/mm² sensitivity

Long term stability allows for high surface binding sensitivity even at very low concentrations. That sensitivity combined with multiplexing makes IRIS ideal for biomarker discovery and disease-specific detection.

Works in real samples

Optical transduction and bulk-effect-free operation make IRIS effective in complex media. Compatible with serum, plasma and cell-culture supernatant, for direct label-free measurement of biologics titre and composition.

Low cost per curve

High sensitivity at a fraction of the instrument cost of SPR or BLI, on silicon substrates made with standard wafer processes. Combined with multiplexing, the cost per binding curve is very low. Chips ship pre-coated, or you coat your own.

How labs already use it.

Six applications, each with a real experiment behind it.

ApplicationWhat was shownEvidence
Antibody and antigen interactionsCandidate antibodies screened for reactivity and selectivity against non-structural protein 1 of Dengue virus, which has four serotypes and needs ligands that recognize all four with high affinity.
Small-molecule binding kineticsCompounds under 1 kDa are hard for platforms sensitive to bulk refractive index. Demonstrated with a compound of roughly 300 Da binding the roughly 25 kDa receptor-binding domain of SARS-CoV-2 spike, the interaction an antiviral would need to block.
SNP detectionA pilot study with three different SNPs on one DNA section. IRIS is capable of measuring over 30 single-point mutations simultaneously from a DNA microarray.
Slow off-rates, measured directlyNegligible drift over experiments lasting many hours, so a slow dissociation rate is measured rather than extrapolated. The MX-104 sheet states direct measurement of off-rates down to 10−6 s−1.
Single-molecule detectionDigital counting of individual binding events. miR-223 and miR-451a were detected below 10 aM using real-time digital microarrays, more than a thousandfold below a conventional analog microarray.
Virus detectionWorking with Prof. Partha Ray at the UC San Diego School of Medicine, a label-free optical biosensor for rapid monkeypox detection returned a result in 20 minutes rather than the hours a PCR test needs. Researchers at BU NEIDL and UTMB used IRIS for rapid Ebola detection.

Interferometric reflectance imaging

How our system works.

IRIS quantifies binding as a change in the optical thickness of a Si/SiO2 substrate, imaged per spot across a microarray. No labels, no reference channel, and no bulk-effect correction.

Two reflections interfere.

The substrate is silicon with a thermally grown SiO2 layer. Incident light reflects at the buffer–oxide interface and again at the Si–SiO2 interface, and the two returns interfere. The spectral reflectivity encodes the optical thickness of the layer. This is the baseline.

bufferSiO2SiincidentR1, oxideR2, siliconpath differencethe two returnsinterfere, and encoden · d
Reflections drawn separated for legibility. In the instrument they return along the same path.

A standard silicon substrate.

Chips come off standard semiconductor production lines: a silicon wafer carrying a single precisely grown oxide layer, with no metal film and no hydrogel above it. Wafer-scale processing gives chip-to-chip consistency in the oxide thickness the measurement depends on.

A bare silicon wafer before spotting, with an iridescent sheen from its oxide film.
A bare wafer before spotting. The sheen is the oxide film, and it is what the measurement reads.

Immobilized probes, printed in replicate.

The oxide surface is functionalised and spotted with capture probes: antibodies, oligonucleotides, receptors. Tens to hundreds of features per array, each printed in replicate, each reporting an independent interaction.

Representative array. Probes printed in triplicate, before sample flows.

Binding adds optical thickness.

As sample flows across the array, analyte binds its probe and the effective optical thickness at that spot increases. The signal responds only to bound mass: no label, no secondary reagent, and no contribution from the bulk refractive index of the running buffer.

Representative array. Probes printed in triplicate, taking on color as bound mass accumulates.

The reflectivity shift is the readout.

Added biomass changes the interference condition, so a loaded spot reflects measurably differently from a bare one. The per-spot shift is converted to bound mass and reported as surface mass density, in pg/mm².

Ensemble read · 6 of 30 ligands · Δ mass, pg/mm²

Ligand 049
Ligand 117
Ligand 025
Ligand 194
Ligand 072
Ligand 231
Representative data. Surface mass density at the end of association.

Our proprietary lighting system means picometer resolution.

Uneven illumination is indistinguishable from bound mass, so evenness sets the noise. Our lighting system diffuses off-the-shelf LEDs in a way that flattens light across the whole chip, making 1 pm of optical thickness readable by the sensor.

Schematic, not an optical layout. Light from the LEDs passes the beam splitter and objective down to the chip; the reflected image returns through the tube lens to the camera.

Continuous imaging yields
the full kinetic trace.

Every spot is imaged simultaneously and repeatedly through the run, so each feature produces a continuous record of bound mass against time. The association rate (kon) and dissociation rate (koff) are fitted from that trace for every spot, and the affinity (KD) follows from their ratio, all in a single experiment.

<1

pg/mm² demonstrated surface mass sensitivity, rivalling SPR

Mplex, July 2026
6

pg/mm² is what 1 ng/mL of IL-6 puts on the surface, label-free

Assay Development Gap, 2026

Both figures are surface mass density, which is what the instrument reports. They come from two different experiments and are not a single measurement, so read them as a floor and a worked example rather than as a ratio.

Binding kinetics · 5 of 30 ligandsΔ mass, pg/mm²2468100048121620samplebuffertime, minutesLigand 04Ligand 02Ligand 11Ligand 19Ligand 07
No bulk effect
Representative data. Association while sample flows, then dissociation once the buffer is switched in, for five of thirty ligands on one chip. Every spot on the array produces a trace like this at the same time, and kon and koff are fitted from it per spot.

Ensemble mode is label-free, real-time quantification of accumulating biomass by reflectance interferometry, and it is the mode that produces the binding curves above. Digital mode, SP-IRIS, counts single binding events using the interferometric contrast of individual nanoparticles: gold nanorods of roughly 70 by 25 nm act as high-contrast scattering labels, so discrete events are counted and tracked down to attomolar concentrations.

App Note IK-12

Kinetics you can trust,
because the data actually fits the model.

Every binding kinetics platform reports a KD. Not every platform’s raw data supports the equation used to calculate it.

A model can be fitted to a distorted trace and it will still return a KD: the number is then what the equation produced, not what the molecules did, which is why the goodness of fit is worth scoring alongside the affinity.

IRIS vs BLI vs SPR

Across dozens of real protein-protein interactions, every fitted curve scored: IRIS stays tightly clustered near a perfect fit in both association and dissociation, where SPR and BLI both show long tails of poor fits.

Proteins and the SPR and BLI dataset were provided by Absea.

Strip chart of R² goodness of fit, higher is better, bar at the median. IRIS (n=34) clusters tightly near 1 with a median of 0.985. BLI per concentration (n=400), BLI pair average (n=62), BLI best concentration (n=62), SPR per concentration (n=235), SPR pair average (n=33) and SPR best concentration (n=71) all show long tails of poor fits down towards R² = 0.
R² distribution, IRIS against BLI and SPR, bar at the median. Every fitted curve in the comparison, scored for goodness of fit. IRIS clusters at a median R² of 0.985; BLI and SPR both show long tails of poor fits.
Example IRIS data for BATF against DDIT3: thickness in nm over time in seconds. The red dashed fitted curve follows the blue experimental trace through association and dissociation. Fitted KD = 10 nM, five times tighter than the SPR fit of the same pair.
IRIS, BATF against DDIT3. The fitted 1:1 model follows the experimental trace through both phases and returns KD = 10 nM.
Example SPR data for BATF against DDIT3: response in RU over time in seconds for five concentrations from 0.56 to 8.8 µM. The black fitted curves diverge from the coloured experimental traces. KD = 53 nM.
SPR, the same pair. The strained fit reports KD = 53 nM, roughly five times weaker than the IRIS value for the same interaction.

In a published study, more than thirty anti-lethal-factor camelid antibodies were profiled in parallel against injected antigen. IRIS-derived kon, koff and KD agreed with previously published SPR values.

Case study: the ligand
SPR could not see.

JMO-B9 registered nothing on SPR. On IRIS it produced a clean binding curve.

In a screening campaign, that is the difference between discarding a candidate and developing it.

Cleaner curves, less second-guessing

Fewer artifacts means fewer manual exclusions, fewer re-runs, and fewer judgement calls about which concentrations to trust.

Affinities you can defend

A KD is only as good as the fit behind it. In the comparison above, IRIS curves fit their binding model with a median R² of 0.985, a fit you can show alongside the number in a paper or a partner meeting.

A check on data you already have

Run IRIS in parallel with SPR or BLI to catch fits that look fine on the surface but are quietly compromised.

A complement,
not a competitor.

“IRIS is not a replacement for ELISA, SPR, BLI, or electrochemical sensors. It is a bridge.”

Closing the Assay Development Gap, Boston University and IRIS Kinetics, 2026. read the review

If your lab runs SPR or BLI, IRIS is not a rival purchase. It is a second, independent measurement of the same interaction, made by a different physical mechanism, on an instrument that costs a fraction of what your primary platform did. Nothing has to come out of the lab to make room for it.

The system, the chips,
and the workflow.

The instrument

A benchtop system with all fluidics on board: three sample channels, flexible configuration, small dead volume, fully automated experiments, and an onboard computer that ships with a keyboard and mouse. Plug and play.

The MX instruments, MX for multiplex, are the research line: the MX-104 ships today and the MX-200 succeeds it.

The chips

A dual-layer silicon chip with a functionalised surface for immobilizing antibodies, nucleic acids, or other capture molecules, assembled into a flow cell with a gasket and cover glass.

Available pre-spotted, including Protein A, G and A/G in ready-to-use cartridges. Or spot your own: the oxide coating is compatible with standard glass surface chemistries. Truly disposable. No reusing old sensor chips.

Spotting your own

IRIS partners with axiVEND, a distributor of M2-Automation spotters. The iFOUR spotter has been customized with a deck for IRIS chips and preloaded spotting programs, so preparing your own arrays is straightforward.

MX-200 specifications

Successor to the MX-104, coming Q1 2027. This is the published specification for an instrument that does not ship yet: sample volume, flow rate, dimensions and power have not been published for it.

MX-200, July 2026
The IRIS MX-200 benchtop instrument, screen raised and showing binding data.
The MX-200. Successor to the MX-104, coming Q1 2027. Not available today.
MultiplexingUp to 100 biomarkers per run
MeasurementReal-time kinetics and endpoint. kon, koff, KD and quantitation.
Reference channelNone required. Shot-noise-limited averaging.
Bulk-effect correctionNone required
FormatBenchtop, single instrument
ConsumableIRIS Chip, single use
AvailabilityQ1 2027
Sample volume, chamber volume, flow rate, fluidics, dimensions, powerOn request from axiVEND

MX-104 specifications

Shipping today. Current specifications, updated since the July 2025 sheet.

MX-104, July 2025
The IRIS MX-104 benchtop instrument: a black enclosure with a blue pump, a fluidics manifold and sample vials on its deck.
The MX-104. Shipping today, sold through axiVEND.
Sample volume100 µL to 2.5 mL per load (syringe size)
Chamber volume2 to 10 µL
Flow rate6.25 µL/min to 5 mL/min
Experiment lengthup to 400 min per cycle, no limit on cycles
Fluidics3 sample channels, flexible configuration, small dead volume
Sensor area5 × 7 mm
Channel height25 µm
Dimensions20 × 12 × 9 in
Weight30 lb
Power120 to 240 V, 70 W
ControlOnboard computer, keyboard and mouse included. Plug and play.

IRIS MX-series instruments and IRIS Chips are for research use only. Not for use in diagnostic procedures.

The IRIS TX-100, the clinical instrument, is in development, is not available for sale, and is not for use in diagnostic procedures. Nothing on this page describes a cleared or approved product.